Literature DB >> 16260629

Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells.

Monica Dentice1, Cristina Luongo, Antonia Elefante, Raffaele Ambrosio, Salvatore Salzano, Mariastella Zannini, Roberto Nitsch, Roberto Di Lauro, Guido Rossi, Gianfranco Fenzi, Domenico Salvatore.   

Abstract

Thyroid transcription factor gene 1 (TTF-1) is a homeobox-containing gene involved in thyroid organogenesis. During early thyroid development, the homeobox gene Nkx-2.5 is expressed in thyroid precursor cells coincident with the appearance of TTF-1. The aim of this study was to investigate the molecular mechanisms underlying thyroid-specific gene expression. We show that the Nkx-2.5 C terminus interacts with the TTF-1 homeodomain and, moreover, that the expression of a dominant-negative Nkx-2.5 isoform (N188K) in thyroid cells reduces TTF-1-driven transcription by titrating TTF-1 away from its target DNA. This process reduced the expression of several thyroid-specific genes, including pendrin and thyroglobulin. Similarly, down-regulation of TTF-1 by RNA interference reduced the expression of both genes, whose promoters are sensitive to and directly associate with TTF-1 in the chromatin context. In conclusion, we demonstrate that pendrin and thyroglobulin are downstream targets in vivo of TTF-1, whose action is a prime factor in controlling thyroid differentiation in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260629      PMCID: PMC1280265          DOI: 10.1128/MCB.25.22.10171-10182.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells.

Authors:  J M Bidart; L Lacroix; D Evain-Brion; B Caillou; V Lazar; R Frydman; D Bellet; S Filetti; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.

Authors:  I E Royaux; K Suzuki; A Mori; R Katoh; L A Everett; L D Kohn; E D Green
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

3.  Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene.

Authors:  W Reardon; C F OMahoney; R Trembath; H Jan; P D Phelps
Journal:  QJM       Date:  2000-02

4.  Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease.

Authors:  H Kasahara; B Lee; J J Schott; D W Benson; J G Seidman; C E Seidman; S Izumo
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.

Authors:  D W Benson; G M Silberbach; A Kavanaugh-McHugh; C Cottrill; Y Zhang; S Riggs; O Smalls; M C Johnson; M S Watson; J G Seidman; C E Seidman; J Plowden; J D Kugler
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues.

Authors:  J M Bidart; C Mian; V Lazar; D Russo; S Filetti; B Caillou; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient.

Authors:  T Hosoda; I Komuro; I Shiojima; Y Hiroi; M Harada; Y Murakawa; Y Hirata; Y Yazaki
Journal:  Jpn Circ J       Date:  1999-05

8.  Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease.

Authors:  W Zhu; I Shiojima; Y Hiroi; Y Zou; H Akazawa; M Mizukami; H Toko; Y Yazaki; R Nagai; I Komuro
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

9.  Transfection of TTF-1 gene induces thyroglobulin gene expression in undifferentiated FRT cells.

Authors:  A Mascia; M De Felice; C Lipardi; R Gentile; G Calì; M Zannini; R Di Lauro; L Nitsch
Journal:  Biochim Biophys Acta       Date:  1997-11-01

Review 10.  A unique combination of transcription factors controls differentiation of thyroid cells.

Authors:  G Damante; G Tell; R Di Lauro
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001
View more
  10 in total

1.  GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.

Authors:  Hong Soon Kang; Dhirendra Kumar; Grace Liao; Kristin Lichti-Kaiser; Kevin Gerrish; Xiao-Hui Liao; Samuel Refetoff; Raja Jothi; Anton M Jetten
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 2.  Transcriptional regulation of the pendrin gene.

Authors:  Julia Rozenfeld; Edna Efrati; Lior Adler; Osnat Tal; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2011-11-16

3.  TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells.

Authors:  Liuska Pesce; Aigerim Bizhanova; Juan Carlos Caraballo; Whitney Westphal; Maria L Butti; Alejandro Comellas; Peter Kopp
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

4.  Association of SLC26A4 mutations with clinical features and thyroid function in deaf infants with enlarged vestibular aqueduct.

Authors:  Satoshi Iwasaki; Koji Tsukamoto; Shinichi Usami; Kiyoshi Misawa; Kunihiro Mizuta; Hiroyuki Mineta
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

Review 5.  Thyroid transcription factors in development, differentiation and disease.

Authors:  Lara P Fernández; Arístides López-Márquez; Pilar Santisteban
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

6.  Comparative genomics reveals a functional thyroid-specific element in the far upstream region of the PAX8 gene.

Authors:  Roberto Nitsch; Valeria Di Dato; Alessandra di Gennaro; Tiziana de Cristofaro; Serena Abbondante; Mario De Felice; Mariastella Zannini; Roberto Di Lauro
Journal:  BMC Genomics       Date:  2010-05-14       Impact factor: 3.969

7.  Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma.

Authors:  Anne-Marie Makhlouf; Zhanna Chitikova; Marc Pusztaszeri; Margaret Berczy; Celine Delucinge-Vivier; Frederic Triponez; Patrick Meyer; Jacques Philippe; Charna Dibner
Journal:  Oncotarget       Date:  2016-07-19

Review 8.  A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review.

Authors:  Avinaash Maharaj; Ruth Kwong; Jack Williams; Christopher Smith; Helen Storr; Ruth Krone; Debora Braslavsky; Maria Clemente; Nanik Ram; Indraneel Banerjee; Semra Çetinkaya; Federica Buonocore; Tülay Güran; John C Achermann; Louise Metherell; Rathi Prasad
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

Review 9.  Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.

Authors:  Li Jing; Qiang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

10.  Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3.

Authors:  Raffaele Ambrosio; Valentina Damiano; Annarita Sibilio; Maria Angela De Stefano; Vittorio Enrico Avvedimento; Domenico Salvatore; Monica Dentice
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.